Drug Shortage Report for BYETTA

Last updated on 2019-02-06
Report ID 73615
Drug Identification Number 02361817
Brand name BYETTA
Common or Proper name exenatide injection
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) EXENATIDE
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1 x 2.4 mL prefilled pen / stylo pré-rempli de 2,4 mL
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-02-05
Actual start date
Estimated end date 2019-03-11
Actual end date
Shortage status Actual shortage
Updated date 2019-02-05
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.